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Abstract - There is increasing evidence that diet plays a 
crucial role in age-related diseases and cancer. Oxidative 
stress is a conceivable link between diet and diseases, thus 
food antioxidants, counteracting the damage caused by 
oxidation, are potential tools for fight age-related diseases 
and cancer. 
Resveratrol (RSV), a polyphenolic antioxidant from 
grapes, has gained enormous attention particularly 
because of its ability to induce growth arrest and apoptosis 
in cancer cells, and it has been proposed as both chemo-
preventive and therapeutic agent for cancer and other 
diseases. Even though the effects of RSV have been 
studied in prostate cancer cells and animal models, little is 
known about its effects on normal cells and tissues. To 
address this issue, we have investigated the effects of RSV 
on EPN cells, a human non-transformed prostate cell line, 
focusing on the relationship between RSV and p66Shc, a 
redox enzyme whose activities strikingly intersect those of 
RSV. p66Shc activity is regulated by phosphorylation of 
serine 36 (Ser36) and has been related to mitochondrial 
oxidative stress, apoptosis induction, regulation of cell 
proliferation and migration. Here we show that RSV 
inhibits adhesion, proliferation and migration of EPN 
cells, and that these effects are associated to induction of 
dose- and time-dependent p66Shc-Ser36 phosphorylation 
and ERK1/2 de-phosphorylation. Moreover, we found that 
RSV is able to activate also p52Shc, another member of 
the Shc protein family. These data show that RSV affects 
non-transformed prostate epithelial cells and suggest that 
Shc proteins may be key contributors of RSV effects on 
prostate cells. 
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I.  INTRODUCTION 
Health or disease is shaped for all individuals by 
interactions between genes and environment and, among 
environmental factors, nutrition plays a key role in 
preventing or causing diseases. The most important 
message of modern research in nutrition is that a diet rich 
in fruit, vegetables, legumes, and whole grains, and which 
includes fish, nuts and low-fat dairy products, protects 
against almost all non-communicable diseases and aging 
[1]. The richness in food antioxidants, which fight the 
detrimental effects of free radicals like Reactive Oxigen 
Species (ROS), are regarded as a major explanation for 
the preventive role of these diets against most 
multifactorial diseases [2]. ROS are physiological 
products of cellular metabolism, and endogenous 
antioxidant enzymes (such as SOD, catalase and GSH) 
control their levels leading to a redox homeostasis 
required for a correct cellular functioning. The redox 
balance can be altered by uncontrolled elevation of ROS, 
which, routed antioxidant system defenses, induces injury 
to lipids, nucleic acids, and proteins, finally causing 
pathological conditions like cancer, diabetes, 
cardiovascular and autoimmune diseases [2]. Thus, dietary 
antioxidants have gained considerable attention for their 
potential chemo-preventive functions [3-6]. A strong 
connection between nutrition and prostate cancer is 
supported by evidence of the large worldwide variations 
in the incidence of this disease, and by the increased risk 
of migrants moving from low-risk to high-risk countries 
[7,8]. In addition, epidemiological studies indicate that 
obese people develop more aggressive prostate cancer 
[9,10]. Oxidative stress is one possible link between 
nutrition and cancer, since high-fat diets increase 
oxidative stress enhancing proliferation of prostate cancer 
cells [11]. Resveratrol (RSV), a dietary polyphenol found 
in high concentrations in grapes, possesses a fascinating 
wide spectrum of biological activities, with remarkable 
clinical potential in cardiovascular and neurodegenerative 
diseases and cancer [12, 13]. Besides its well- recognized 
antioxidant, anti-inflammatory, growth inhibiting, and 
pro-apoptotic activities, RSV also mimics caloric 
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restriction [14]. However, despite large efforts, the 
mechanisms underlying RSV chemo-preventive effects 
remain still elusive [14,15], mostly because RSV exerts its 
action through multiple targets, whose downstream effects 
are dramatically influenced by experimental system, dose, 
concentration, and duration of treatment. In line with these 
considerations, the overall conclusion of “Resveratrol 
2012” working group was: “There is not yet sufficient 
evidence to link a specific direct target to a specific health 
benefit. To date, published evidence from human trials is 
not sufficiently strong to justify the recommendation of 
chronic resveratrol consumption by humans for any given 
indication. The use of resveratrol is not an alternative to 
maintaining a healthy lifestyle.” [15].  
Considering that, for chemoprevention, RSV 
should be chronically administered to healthy people, the 
issue of the long term effects of this molecule on normal 
tissues is crucial. Although the majority of mechanistic 
studies demonstrate that RSV affects aberrant molecular 
pathways in tumor cells, in most reports the normal cell 
counterpart is missing. Moreover, several evidence 
indicate that also normal cells such as endothelial cells, 
lymphocytes, smooth muscle cells, chondrocytes, 
adipocytes, neurons, osteoblasts, hepatic cells, and 
epidermal keratinocytes [16-19] are vulnerable to RSV. 
To contribute to this important issue, our interest has been 
and is to investigate the effects of RSV in non-
transformed human cells. 
Similar to RSV, also p66Shc, a member of the 
Shc family of adaptor proteins, is attracting interest [20-
22]. Under oxidative stress condition p66Shc undergoes 
transient phosphorylation at tyrosine residues, and also at 
Ser36 [22], acquiring redox enzymatic activity that 
generates ROS in mitochondria. P-Ser36-p66Shc-induced 
oxidation of cytochrome c contributes to inactivate 
members of the Forkhead transcription factor family, and 
down-regulate the expression of antioxidant genes 
consequently leading to growth arrest and apoptosis [21]. 
On the other hand, the other two members proteins 
encoded by the SHC1 gene, p46Shc and p52Shc, undergo 
tyrosine phosphorylation in response to cytokines and 
growth factors, activating the RAS-MAPK pathway and 
promoting cell proliferation and differentiation. Thus, the 
three Shc proteins display distinct physiological roles and 
P-Ser36-p66Shc functions as a dominant-negative 
regulator of p46/52 Shc by terminating RAS/ERK 
activation [21]. Despite the fact that many studies imply 
p66Shc as a mediator of apoptosis, recent studies also 
associate p66Shc with human epithelial cell proliferation 
and carcinogenesis. In addition, recent evidence indicates 
that p66Shc can exert pleiotropic effects on a range of 
apparently unrelated fundamental biological processes, 
like cellular adhesion, cytoskeletal morphology and 
intracellular calcium homeostasis [23-26]. These 
apparently contradictory results suggest that the biological 
outcome of p66Shc signaling is more nuanced and might 
be diverse in different cellular context. Similarly, the 
canonical, established and distinct roles of the three Shc 
isoforms are challenged by new results, suggesting that 
also p52Shc and p46Shc, not only p66Shc, are involved in 
energy metabolism, and in the metabolic response to over-
nutrition and caloric restriction. Interestingly, it has been 
reported that Shc proteins expression correlates with 
proliferation of human prostate cancer cells and it is 
upregulated by steroid hormones in hormone-sensitive 
cancer cells and in primary prostate carcinomas [27-30]. 
Strikingly to us, RSV and p66Shc share similar 
molecular targets involved in the regulation of the same 
major cellular events, like proliferation and differentiation 
(FoxO, MnSOD, p27Kip, NF-kB, AKT, ERK, p53, p21) 
[31-34]. Consistently with these observations, we have 
previously reported that RSV induces ERK-independent 
Ser36 phosphorylation of p66Shc in HaCaT cells, a well-
known model of human non-transformed keratinocytes 
[19]. Since RSV and Shc proteins are implicated by 
differing means in prostate cancer, to get a deeper insight 
in the effects of RSV on normal epithelial cells and in its 
association with p66Shc, here we utilized the non-
transformed prostate epithelial EPN cell line [35]. Our 
results show that in EPN cells RSV reduces adhesion and 
migration, induces growth arrest, stimulates Ser36-p66Shc 
phosphorylation and abolishes ERK phosphorylation. 
Finally, our data indicate that RSV profoundly affects 
non-transformed prostate cells and that its effects may be, 
at least in part, exerted via a connection with Shc proteins.  
 
II. METHODOLOGY 
Cell culture and proliferation EPN cells, spontaneously 
immortalized prostate epithelial cells, derived from human 
normal prostate tissue, were obtained in our laboratory 
[35]. EPN-PKM3 cells have been obtained by transfection 
of EPN cell with a plasmid bearing PKM, a kinase-
negative mutant of PYK2, as previously described [36]. 
EPN and EPN-PKM3 cells are routinely cultured in 
Dulbecco Modified Eagle Medium/HAM F12 
(DMEM/F12) supplemented with 3% FBS and 1% 
antibiotics at 37°C, 5% CO2, in a humidified incubator. 
HeLa cells were cultured in DMEM supplemented with 
10% FBS and 1% antibiotics at 37°C, 5% CO2, in a 
humidified incubator [37]. 
Cell adhesion assay Adhesion of EPN and EPN-PKM3 
cells in the presence or absence of RSV was analyzed by 
Crystal Violet assay according to Humphries [38]. EPN 
and EPN-PKM3 cells were seeded at a concentration of 
105 in 24 well culture plates and let to adhere for 1, 2 or 4 
hours in complete medium supplemented with different 
concentrations of RSV. For growth assay EPN and EPN-
PKM3 cells were seeded in at a concentration of 105 in 24 
well culture plates and let to adhere for 18 hours in 
complete medium, then RSV (25 and 100 µM) was added 
and cells were cultured for additional 48 hours. At the end 
of the incubation time cells were washed three times with 
cold PBS then Crystal violet solution (0,25% crystal violet 
in 25% methanol) was added for 15’ at room temperature. 
After de-staining by extensive washing with distilled 
water, cells were solubilized in 500 μl of 0,1% SDS and 
OD at 590 nm was determined by spectrophotometry. 
Adhesion assay were performed in quintuplicate. 
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MTT assay EPN and EPN-PKM3 cells were seeded in 96 
well plates in standard medium and let adhere for 24 
hours, then standard medium was replaced with standard 
medium supplemented with different concentrations of 
RSV (1, 10, 100 and 200 µM) as detailed in the figure 
legend. After 24 hours CellTiter 96® AQueous One 
Solution Cell Proliferation Assay was performed 
according to manufactures. Formazan formation was 
assessed by absorbance at 490nm with a 96-well plate 
reader. 
Motility assay EPN cells maintained in standard medium 
for 48 h were dispersed with versene, washed twice, re-
suspended in DMEM/F12 and counted using a 
hemocitometer. The 24-well modified Boyden chambers, 
containing porous (8 mm) polycarbonate membranes, 
were coated, on the internal surface, with 2 mg/cm2 P-Lys 
by incubation at room temperature. The lower chambers 
were loaded with 500 μl of DMEM/F12 supplemented 
with 3% FCS, while synchronized cells (2x104) suspended 
in 200 μl of KSFM 3% FCS, were plated into upper 
chambers in presence or absence of different treatments as 
indicated. After 6 h of incubation in 5% CO2 at 37°C, the 
cells in the upper chamber were removed by a cotton 
swab, so that only cells that had migrated through the 
membrane remained. The membranes were then fixed and 
stained in Coomassie blue solution (0.25 Coomassie blue, 
45 ml water, 45 ml methanol, 10 ml glacial acetic acid) for 
5 min, then each well was rinsed three times with distilled 
water. The migrated cells were counted using an inverted 
microscope. 
Wound healing EPN and EPN-PKM3 cells, grown to 
90% confluence in standard condition, were maintained in 
serum-free medium for 48 h. The monolayers were 
scratched with a sterile, disposable 200-ml plastic pipette 
tip, rinsed twice with phosphate-buffered saline (PBS) and 
returned to standard medium in presence or absence of 
3μM PP2, 20 μMUO126 and 100μM RSV. Then 
monolayers were photographed after 24 h. 
Western blotting Cells were grown to sub-confluence in 
standard medium and serum-starved for 24 hours. Then, 
medium was supplemented with RSV at varying 
concentrations or times as indicated in the figure legends. 
Cells were harvested in lysis buffer (50 mM HEPES, 150 
mM NaCl, 1 mM EDTA, 1 mM EGTA, 10 % glycerol, 1 
% Triton-X-100, 1 mM phenylmethylsulfonyl fluoride, 
protease inhibitor cocktail tablet, 0.5 mM sodium 
orthovanadate, 20 mM sodium pyrophosphate). The 
lysates were incubated for 30 min on ice and then clarified 
by centrifugation at 14,000 rpm x 10 min. Total protein 
concentration was estimated by a modified Bradford 
assay. For Western blot, 25 or 50 g/lane of total proteins 
were separated on 10% SDS-polyacrylamide gel 
electrophoresis and transferred to PVDF membranes; 
complete transfer was assessed using pre-stained protein 
standards. Membranes were blocked in TBS/T buffer (25 
mM Tris, pH 7.4, 200 mM NaCl, 0.5% Triton X-100), and 
5% non-fat powdered milk for 1 hour at room 
temperature. Incubation with the primary antibody anti 
ERK1/2 1:2000, anti-phospho-ERK1/2 1:2000, anti AKT 
1:1000, anti phospho-AKT 1:1000, anti p(tyr 317) Shc 
1:1000,  anti GADPH 1:1000, was carried out overnight in 
the cold room. Finally, membranes were incubated with 
the horseradish peroxidase-conjugated secondary antibody 
(1:3000) for 45 minutes at room temperature and the 
reactions detected with ECL system. 
IPP procedure One mg of whole cell lysates from EPN 
and EPN-PKM3 cells in the various experimental 
conditions, was immune-precipitated by incubation over 
night, at 4 °C, with protein A-sepharose-bound anti-Shc 
polyclonal antibody (4 µl of anti-Shc antibody previously 
conjugated with 5 mg of protein A-sepharose). Following 
washings, and resuspension in 30 µl of a standard 
denaturing protein loading buffer, samples were heated at 
70°C for 30 minutes, cleared by a short centrifugation, 
subjected to 10% SDS-polyacrylamide gel 
electrophoresis, and transferred to nitrocellulose. 
Membranes underwent Western Blotting analysis with an 
anti-phospho-Ser36p66Shc monoclonal antibody (1:1000 
dilution; or with an anti-Shc monoclonal antibody (1:1000 
dilution) to control for the total amount of Shc isoforms. 
Finally, the membranes were incubated with the 
horseradish peroxidase-conjugated secondary antibody 
(1:3000) for 45 minutes at room temperature and the 
reactions detected with ECL system. 
Statistical analysis Data are presented as mean ± SD. 
Statistical analysis was performed by analysis of variance 
followed by the Bonferroni test. P-values <0.05 were 
considered statistically significant. 
 
III.  RESULTS 
RSV inhibits adhesion, proliferation and migration of 
EPN and EPN-PKM3 cells. Non-transformed human 
epithelial prostate EPN cells have been selected as model 
in which to study the effects of RSV. As a control, we 
used their counterpart EPN-PKM3 cells, which express a 
Proline-rich tyrosine kinase (PYK2) dead kinase mutant, 
and display some tumour-like features, like increased cell 
motility and migration, and cytoskeleton reorganization 
[39-42]. PYK2, a non-receptor kinase of the focal 
adhesion kinase (FAK) family, regulates several cellular 
functions, like proliferation, apoptosis, actin cytoskeleton 
organization and adhesion, and its expression inversely 
correlates with degree of malignancy of prostate cancer 
[43]. Since cell adhesion is a key event for epithelial cells 
to survive and proliferate, we investigated adhesion of 
EPN and EPN-PKM3 cells in the presence or in the 
absence 
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Fig. 1. Effect of RSV on EPN and EPN-PKM3 cells adhesion and viability. A) Cell adhesion assay. Bars represent the 
mean of three independent experiments ± SD. Quintuplicate measurements were performed per each experimental point. 
Statistical analysis was performed by analysis of variance followed by the Bonferroni test (*P < 0.05).  
B and C) Viability and proliferation of EPN and EPN-PKM3 cells in the presence of increasing concentrations of RSV 
(MMT assay Fig 1 B, Cristal Violet assay Fig.1 C). Triplicate measurements were performed per each experimental 
point. Data represent the mean of three independent experiments ± SD. Statistical analysis was performed by analysis of 
variance followed by the Bonferroni test (*P < 0.05).  
 
of RSV. We performed an adhesion assay as described by 
Humphreis (38), and the effect of RSV on the adhesion of 
EPN and EPN-PKM3 cells was evaluated at 1, 2 and 4 
hours after seeding. RSV (25, 100 µM) reduced EPN and 
EPN-PKM3 cells adhesion in a dose-dependent manner 
(Fig. 1A). 
The effect of RSV on EPN and EPN-PKM3 cells viability  
and proliferation have been tested by MTT assay and 
Crystal Violet assay. EPN and EPN-PKM3 cells were 
seeded in standard medium, and 24 hours later increasing 
concentrations of RSV (1, 10, 25, 50 and 100 µM) were 
added for additional 24 hours. RSV reduced viable cells in 
a dose-dependent manner, and RSV growth inhibitory 
effect was more potent in EPN-PKM3 cells than in EPN 
cells (Fig. 1B). Similar results were obtained when cell 
viability and proliferation were tested by means of Crystal 
Violet assay (Fig. 1C). Finally, we investigated the effects 
of RSV treatment on migration, using a modified Boyden 
Chamber assay, in the absence of extracellular matrix 
(ECM) proteins (Fig. 2A). EPN and EPN-PKM3 cells 
were serum starved for 48 h, removed with versene (a 
non-proteolytic chelating agent), and seeded on poly-
lysine coated Boyden chamber. After 6 hours, migration  
 
was observed in both EPN and EPN-PKM3 cells and, as 
expected, it was higher in EPN-PKM3 than in EPN cells. 
50 µM RSV treatment was able to drastically abrogate the 
migration in both cell types, although the magnitude of 
change was greater in EPN-PKM3 cells. Migration is 
regulated, among others by c-SRC and MAPK pathways, 
thus we tested the effect of PP2 and UO126, well-known 
inhibitor of c-SRC and MEK respectively, on EPN and 
EPN-PKM3 migration. Interestingly, the anti-migratory 
effect of RSV was by far more potent than that of PP2 and 
UO126. Moreover, we assessed migration by wound 
healing (Fig. 2B). After inflicting a wound, EPN and 
EPN-PKM3 cells monolayers were extensively washed 
with PBS and then maintained in serum free medium in 
the presence or the absence of 25 and 100 µM RSV or 20 
µM UO126. After 24 hours, RSV was able to drastically 
inhibit wound closure at both 25 and 100 µM 
concentration. The MEK inhibitor-UO126 was less 
effective than RSV in preventing wound closures in both 
EPN and EPN-PKM3 cells. 
RSV fails to induce ERK phosphorylation in EPN and 
EPN-PKM3 cells. The growth inhibitory effect of RSV 
has been associated to both ERK 1/2 activation 
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Fig. 2. RSV inhibits migration of epithelial prostate cells. A) EPN and EPN-PKM3 cells were serum starved for 48 h. 
Synchronized cells were then plated on polylisine-coated Boyden chambers (as indicated in Methodology) in the absence 
or presence 3μM PP2, UO126 and RSV. After 6 hours, cells that migrated through and adhered to the under surface of 
the membranes were fixed, stained, and counted using an inverted microscope. B) EPN and EPN-PKM3 cells monolayers 
were scrape-wounded and cultured in presence or absence of different compounds, in the absence of serum. The 
morphology of wound closure was photographed after 24 h. 
 
and inactivation [44]. To avoid confounding interference 
of serum on RSV effect, EPN and EPN-PKM3 cells were 
serum starved for 24 hours before a 30’ treatment with 
increasing concentration of RSV (1, 10 and 100 µM). We 
chose a range of RSV concentrations encompassing both 
doses achievable with diet (1-10 µM) and a 
pharmacological one (100µM). RSV acute treatment did 
not induce ERK 1/2 phosphorylation at any concentration 
tested in EPN cells, whereas a slight ERK activation was 
observed at 100 µM RSV in EPN-PKM3 cells (Fig. 3A). 
We then tested whether RSV would interfere with serum-
induced ERK 1/2 activation. To this aim, EPN and EPN-
PKM3 cells were pre-treated with 100 µM RSV for 24 
hours, and then stimulated with FCS for 15 min. As 
shown in Fig. 3B, RSV was able to strongly reduce FBS-
induced ERK 1/2 rapid phosphorylation. Similarly, RSV 
added to serum chronically stimulated cells also inhibited 
ERK activation (Fig. 3C). Moreover, we found that RSV 
did not affect the total amount of ERK 1/2 proteins in all 
the experimental conditions.  
RSV induces p52Shc tyrosine phosphorylation and 
p66Shc serine 36 phosphorylation. Shc adaptor 
proteins are phosphorylated at tyrosine residues Tyr239,  
 
Tyr240 and Tyr317 in response to various growth factors 
and cytokines. The phosphorylated p46 and p52 isoforms 
transmit signals from receptor tyrosine kinases to the 
RAS-MAPK pathway, finally inducing mitogenesis. 
Beside their well-known effect on the regulation of cell 
proliferation, Shc family members are also involved in the 
regulation of cytoskeleton rearrangement and migration. 
On the base of these information, we first tested the effect 
of RSV on Shc Tyr317 phosphorylation. Acute treatment 
of EPN and EPN-PKM3 with RSV (1 to 100 µM) resulted 
in tyrosine phosphorylation of p52 and p66Shc isoforms at 
100 µM. These phosphorylations peaked at 15 minutes 
slightly decreasing thereafter (Fig. 4). Moreover, we did 
not observe any significant change in the total amount of 
Shc proteins when the filters were re-probed with an 
antibody recognizing total Shc proteins. 
p66Shc appears to be functionally different from the p46 
and p52 isoforms, and, although it is tyrosine-
phosphorylated, Ser36 phosphorylation seems to be the 
main regulator of its activation. When EPN and EPN-
PKM3 cells were acutely stimulated with increasing 
concentration of RSV (1 to 100 µM), a dose-dependent 
increase of the levels of P-Ser36-p66Shc was observed
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Fig. 3. Effect of RSV on ERK1/2 activation. A) A representative WB analyzing the dose–response effect of 1, 10 and 
100 μM RSV on ERK1/2 phosphorylation in EPN and EPN-PKM3 cells. B) A representative WB analyzing the effect of 
24 hours 100 μM RSV pre-treatment on ERK1/2 activation induced in EPN and EPN-PKM3 cells by 15’ minutes 
stimulation with 3% FBS. C) A representative WB analyzing the effect of 100 μM RSV on ERK1/2 phosphorylation in 
EPN and EPN-PKM3 cells starved or chronically stimulated with 3% FBS. 
 
Fig. 4. Effect of RSV on pShc Tyr-phosphorylation. A) A representative WB analyzing the dose–response effect of 
RSV (1, 10 and 100 μM) on pShc Tyr317 phosphorylation in EPN and EPN-PKM3 cells. Cell lysates were 
immunoprecipitated with anti-Shc antibodies prior WB analysis as described in details in Material and Methods. B) A 
representative WB analyzing the time course of the effect of 100 μM RSV on pShc Tyr 317 phosphorylation in EPN- and 
EPN-PKM3 cells at 5′, 15′, 30, 60′ and 120′. 3%FCS was used as an internal control. Cell lysates were 
immunoprecipitated with anti-Shc antibodies prior WB analysis. 
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Fig. 5. Effect of RSV on p66Shc Ser36 phosphorylation. A) A representative WB analyzing the dose–response effect 
of RSV (1,10 and 100 μM) on p66Shc Ser36 phosphorylation in EPN and EPN-PKM3 cells. Cell lysates were 
immunoprecipitated with anti-Shc antibodies prior WB analysis.) A representative WB analyzing the time course of the 
effect of 100 RSV on p66Shc Ser36 phosphorylation in EPN- and EPN-PKM3 cells at 5′, 15′, 30, 60′ and 120′. 3%FCS 
was used as an internal control. Cell lysates were immunoprecipitated with anti-Shc antibodies prior WB analysis as 
described in details in Material and Methods.  C) A representative WB analyzing the effect of 20 μm UO126 on RSV-
induced phosphorylation of ERK and Ser36 p66Shc. EPN and EPN-PKM3 cells were pretreated with 20 μm UO126 for 
6 h followed by 30′ treatment with 100 μm RSV. As a control, cells were stimulated with 3% FCS after U0126 
pretreatment. Cell lysates were immunoprecipitated with anti-Shc antibodies prior WB analysis as described in details in 
Material and Methods. 
 
 (Fig. 5A). However, EPN and EPN-PKM3 display a 
different sensitivity to the stimulating activity of RSV. In 
fact, P-Ser36-p66Shc phosphorylation is induced at diet 
achievable concentrations (1 and 10 µM) in EPN-PKM3 
cells, and at pharmacological doses (100 µM) in EPN 
cells. P-Ser36-p66Shc phosphorylation peaks at 30 
minutes upon 100 µM RSV stimulation and declined at 
120 min in both EPN and EPN-PKM3 cells (Fig. 5B).  
ERK has been implicated in p66Shc phosphorylation in 
response to endothelin, taxol and H2O2 [45, 47]. In 
addition, Suen and co-workers reported a direct 
interaction between p66Shc and ERK [48]. To further 
investigate whether in EPN and EPN-PKM3 cells RSV 
effect on p66Shc is independent on ERK, we tested the 
effect of MEK inhibitor UO126 on serum- and RSV-
induced p66Shc Ser36 phosphorylation. UO126 wipes out 
serum-induced P-Ser36-p66Shc, but it fails to affect RSV-
induced Ser-36 phosphorylation (Fig 5C). These data 
suggest that, in our experimental setting, RSV induces Shc 
tyrosine phosphorylation and p66Shc Ser36 
phosphorylation in an ERK-independent manner. 
RSV is not able to induce Ser36-p66Shc phosphorylation 
in HeLa cells. To test whether the ability of high 
concentration of RSV to induce Ser36-p66Shc 
phosphorylation is a common effect of the phytoalexin on 
any cell type, we tested the relation between RSV and 
p66Shc also in HeLa cells, a well-recognized model of 
cervical cancer in culture [37]. Over-night serum starved  
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Fig. 6. Effect of RSV on p66Shc Ser36 phosphorylation in HeLa Cells, and effect of EGCG on EPN cells viability 
and on p66Shc Ser36 phosphorylation in EPN and EPN-PKM3 cells. A) A representative WB analyzing the effect of 
acute treatment of 100 μM RSV on FBS-stimulated Ser36-p66shc phosphporylation in serum starved HeLa, EPN and 
EPN-PKM3 cells. Cell lysates were immunoprecipitated with anti-Shc antibodies prior WB analysis. B) The effect of 
EGCG (25, 50 and 100μM) on EPN cell viability. Triplicate measurements were performed per each experimental point. 
Data represent the mean of three independent experiments ± SD. Statistical analysis was performed by analysis of 
variance followed by the Bonferroni test.*P < 0.05. C) A representative WB analyzing the dose–response effect of 
EGCG (1,10 and 100 μM) on p66Shc Ser36 phosphorylation in EPN and EPN-PKM3 cells. Cell lysates were 
immunoprecipitated with anti-Shc antibodies prior WB.  D) A representative WB analyzing the time course of the effect 
of 100 EGCG on p66Shc Ser36 phosphorylation in EPN- and EPN-PKM3 cells at 5′, 15′, 30, 60′ and 120′. 3%FCS was 
used as an internal control. Cell lysates were immunoprecipitated with anti-Shc antibodies prior WB. 
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HeLa cells were pretreated for 30 min with FBS, and then 
stimulated for 15 min with RSV 100 µM. Serum induced 
Ser36-p66Shc phosphorylation (Fig. 6A), whereas RSV 
had no per se effect on Ser36-p66Shc phosphorylation in 
HeLa cells. However, RSV decreased serum-induced 
p66Shc Ser36 phosphorylation. 
EGCG regulates EPN cell proliferation and induces 
p66Shc serine 36 phosphorylation. Finally, to investigate 
whether the ability of RSV to induce Ser36p66Shc 
phosphorylation is a common feature of other antioxidant 
molecules, we tested Epi-gallo-catechin Gallate (EGCG), 
the major and the most active component of green tea and 
of the Asian diet. EGCG exerts anti-oxidant and anti-
inflammatory effects protecting from DNA damage, LDL 
oxidation, lipid peroxidation, oxidative stress and 
production of nitric oxide (NO) radicals, the latter effect 
due to the inhibition of the expression of iNOS. EGCG 
also lowers the overproduction of pro-inflammatory 
cytokines and mediators, reduces the activity of NF-kB 
and AP-1, and the subsequent formation of peroxynitrite, 
NO and ROS. Green tea is proposed to be a dietary 
supplement for the prevention of cardiovascular diseases, 
in which oxidative stress and inflammation are the 
principal causes after the establishment of hyperlipidemia. 
Additionally, the cancer-preventive effects of green tea 
are widely supported by results from epidemiological, cell 
culture, animal and clinical studies [49-51]. 
In vitro cell culture studies show that tea polyphenols 
potently induce apoptotic cell death and cell cycle arrest in 
tumor cells but not in their normal counterparts [52]. Here, 
we found that treatment of EPN cells with increasing 
concentration of EGCG  (25, 50 and 100 µM) results in a 
dose-dependent inhibition of cell proliferation. The 
inhibitory effect of EGCG was observed after 48 hours 
and was more pronounced at the higher concentration 
(100 µM) (Fig. 6B). Of note, the inhibitory effect of 
EGCG was by far lower than that of RSV at the same 
concentrations. On the other hand, at the same 
concentration tested for RSV (1 to 100 µM), EGCG was 
able to induce phosphorylation of p66Shc in Ser36 (Fig. 
6C and 6D). 
 
IV.  DISCUSSION 
The effect of RSV on normal cells is a key issue for a safe 
exploitation of the clinical potential of this molecule in 
humans. In the present work, we report that RSV 
influences different functions in EPN cells, a model of 
non-transformed prostate epithelial cells, and in their 
counterpart bearing a kinase-negative mutant of the non-
receptor kinase PYK2. In particular, RSV inhibits cell 
adhesion, cell migration and cell viability of EPN and 
EPN-PKM3 cells. Well aware of conclusions and 
recommendation of “Resveratrol 2012” working groups, 
we have used concentration of RSV both in the range 
achievable with diet (1nM to 25 µM) and in the 
pharmacological one (50 to 100 µM). In EPN and EPN-
PKM3 cells adhesion is significantly reduced at 100 µM 
RSV, whereas both viability and migration are already 
reduced at 25 µM. In addition, migration assays indicate 
that the anti-migratory effect of RSV is more potent than 
that of PP2 (SRC inhibitor) and UO126 (MEK inhibitor). 
To trace back the molecular bases of inhibitory action of 
RSV, we have analyzed its effect on the members of the 
Shc family adaptor proteins. In EPN and EPN-PKM3 
cells, RSV induces a time- and dose-dependent 
phosphorylation of Shc proteins. In particular, RSV 
increases p52Shc and p66Shc tyrosine and p66Shc Ser36 
phosphorylation.  
Moreover, RSV fails to induce ERK phosphorylation, and 
decreases serum-induced ERK activation, in both acute 
and long-term treatment. Since a physical and functional 
interaction between ERK and Shc proteins has been 
described, we tested the role of the MEK inhibitor UO126 
on p66Shc phosphorylation. UO126 wipes out serum-
induced, but not RSV-induced, Ser36-p66Shc 
phosphorylation. Interestingly, the effect of RSV on 
p66Shc activation is apparently dependent on the cellular 
context, since in HeLa cells RSV fails to induce p66Shc 
Ser36 phosphorylation. Conversely, activation of p66Shc 
phosphorylation is not restricted to the sole RSV, since it 
is also induced by EGCG, another well-known food 
antioxidant, in EPN and EPN-PKM3 cells.  
The data presented here suggest that, in our experimental 
setting, Shc phosphorylation does not correlate with cell 
proliferation, neither in the case of RSV nor in that of 
EGCG. The estrogen-like behavior of RSV is one possible 
explanation of this observation. Intriguingly, there are 
multiple connections between estrogens, RSV and Shc 
proteins: RSV binds estrogens receptors; α5ß3 integrin, 
recognized as RSV receptor, presents specific binding 
sites for steroids [53,54]; estrogens induce p52Shc 
activation [55,56] which, in turn, has been identified as a 
primary signaling partner for the tyrosine(s)-
phosphorylated cytoplasmic tails of activated α5ß3 
integrin [57]. However, other molecular pathways 
connecting RSV and SHC such as calcium regulation can 
not be ruled out. 
Beside its proapoptotic role, p66Shc activation is associate 
also to the regulation of cell proliferation, migration, 
cytoskeleton rearrangement, differentiation, senescence 
and, last but not least, autophagy. Thus, these non 
canonical p66Shc effects may represent one of the 
possible mechanisms through which RSV controls 
prostate epithelial cells functions. Within the context of 
our experimental setting, it is possible to speculate that 
RSV-induced p52Shc tyrosine phosphorylation drives 
p66Shc Ser36 phosphorylation which, competing with 
p46Shc and p52Shc for Grb2 binding, inhibits p52Shc 
mediated RAS-MAPK proliferative stimulus and 
consequently induces growth arrest, inhibits cell migration 
and motility. Noteworthy, although RSV induces 
“qualitative“ same effecs in EPN and EPN-PKM3 cells, 
from the “quantitative” stand point the effects differ in the 
two cell line. In that, RSV achieves the same effect in 
EPN-PKM3 cells at lower doses than in EPN cells, on the 
other hand at the same dose the extent of RSV effects 
differs in the two cell lines.  
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In conclusion, the data presented here indicate once more 
that in a model of non-transformed epithelial cells, RSV 
induces growth arrest, modification of enzyme activity 
and/or cell signaling pathways. For this reason, before 
RSV could be safely recommended for its potential 
beneficial effects on human health, its effect on normal 
cells need to be extensively investigated. 
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